For example, downregulation of GRK2, GRK3, GRK5, and GRK6 promoted tumorigenesis and metastasis in Kaposi sarcoma, basal-like breast cancer, colon cancer, and medulloblastoma [17, 31–34]. This evidence concerns the gene GRK2 and colonic neoplasm.